Glen Clova Scientific
1 known investors
Glenclova Scientific develops a virus-like particle (VLP) platform that displays therapeutic proteins and peptides to enhance the efficacy and reduce the dosage requirements of biologic drugs. The platform targets chronic disease treatments, particularly for inflammatory, respiratory, dermatological, and oncological indications, with a focus on improved accessibility and affordability for resource-limited healthcare settings.
Founders & leadership
DJ
Dr John FoersterScientific Founder
JH
Jamie HodgsoninChief Executive Officer
Investors · 1
Frequently asked questions
- What does Glen Clova Scientific do?
- Glenclova Scientific develops a virus-like particle (VLP) platform that displays therapeutic proteins and peptides to enhance the efficacy and reduce the dosage requirements of biologic drugs. The platform targets chronic disease treatments, particularly for inflammatory, respiratory, dermatological, and oncological indications, with a focus on improved accessibility and affordability for resource-limited healthcare settings.
- Who founded Glen Clova Scientific?
- Glen Clova Scientific was founded by Dr John Foerster.
- Who are Glen Clova Scientific's investors?
- Glen Clova Scientific's investors include DSW Ventures.